ICON’s Medical and Safety Services Group offers safety support across all stages of the product lifecycle by providing efficient drug safety processes, compiling concise drug safety profiles, and developing tailored risk-management strategies. We provide high quality full-service pharmacovigilance within all regions of the world using various models, including low-cost and off-shore options and our Total Product Safety Centre (TPSC) can handle every aspect of your marketed product's needs.

Our global safety team, including more than 300 medical and scientific experts, is located in five main safety centres in the Americas, Europe, and Asia. This highly experienced team is focused on post-marketing drug safety, pharmacovigilance, and risk management. Our commitment to quality is reflected in excellent audit ratings from internal auditors, sponsors, and major regulatory authorities.

We can provide highly responsive, multi-lingual, customised pharmacovigilance services, from small studies to complex, multinational projects. These can be deployed on a standalone basis or as part of an integrated “full service” solution.

• Medical Affairs
• Drug Safety
• Medical Writing
• Phase IV & Safety Registries
• Consultancy Services

ICON has significant experience in all major safety databases, including both commercial and proprietary systems. Our team has grown organically more than 30% per year (staff and revenue) over the last 5 years. We can provide high-quality, full-service pharmacovigilance within all regions of the world using various models, including low-cost and off-shore options.